Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential ...
During the ongoing government shutdown, ClinicalTrials.gov, the nation’s central registry for medical research and clinical ...
The law firm of Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Bridgewood v. MoonLake Immunotherapeutics, No. 25-cv-08500 (S.D.N.Y.) – seeks to represent ...
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / October 17, 2025 / UniDoc Health Corp.
Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 third quarter results at 8:30 a.m. CDT on Friday, October 31, 2025. Investors may access the live ...
Roseman University of Health Sciences and PDS Health® celebrated the dedication and ribbon-cutting of the new Thorne Clinic ...
The "Ultrasonic Cleaner Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering.The global ultrasonic cleaning market is expected to grow at a CAGR of 6.66% from ...
Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year -- Second pivotal development ...
Avanzanite entered an exclusive partnership with Agios in June 2025 to manage PYRUKYND commercialization across EuropeEuropean Commission will now review the CHMP’s opinion, with the final decision ...
MESA, ARIZONA / ACCESS Newswire / October 17, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today outlines the tremendous scalability and market potential of its proprietary AI ecosystem, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback